IRIS
USIELLO, Alessandro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.964
NA - Nord America 4.887
AS - Asia 3.235
SA - Sud America 562
Continente sconosciuto - Info sul continente non disponibili 379
AF - Africa 40
OC - Oceania 3
Totale 17.070
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 5.132
US - Stati Uniti d'America 4.771
SG - Singapore 1.262
IE - Irlanda 894
CN - Cina 643
HK - Hong Kong 482
IT - Italia 479
BR - Brasile 466
UA - Ucraina 383
VN - Vietnam 370
GB - Regno Unito 340
DE - Germania 244
TR - Turchia 114
FI - Finlandia 111
SE - Svezia 110
KR - Corea 93
IN - India 82
GR - Grecia 73
NL - Olanda 59
JP - Giappone 54
CA - Canada 53
FR - Francia 46
AR - Argentina 36
MX - Messico 31
AT - Austria 30
BD - Bangladesh 25
ID - Indonesia 18
IQ - Iraq 18
EC - Ecuador 14
ZA - Sudafrica 14
BE - Belgio 13
PK - Pakistan 12
CL - Cile 11
UZ - Uzbekistan 11
VE - Venezuela 11
CO - Colombia 10
ES - Italia 10
JM - Giamaica 7
PL - Polonia 7
MA - Marocco 6
AE - Emirati Arabi Uniti 5
CR - Costa Rica 5
CZ - Repubblica Ceca 5
HN - Honduras 5
KE - Kenya 5
PE - Perù 5
PY - Paraguay 5
SA - Arabia Saudita 5
TT - Trinidad e Tobago 5
CH - Svizzera 4
JO - Giordania 4
LT - Lituania 4
MY - Malesia 4
NP - Nepal 4
TH - Thailandia 4
TN - Tunisia 4
UY - Uruguay 4
AM - Armenia 3
BH - Bahrain 3
EU - Europa 3
KG - Kirghizistan 3
PH - Filippine 3
PT - Portogallo 3
AL - Albania 2
AU - Australia 2
BB - Barbados 2
DK - Danimarca 2
EE - Estonia 2
ET - Etiopia 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
KZ - Kazakistan 2
LB - Libano 2
NG - Nigeria 2
PR - Porto Rico 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
AO - Angola 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
BG - Bulgaria 1
BS - Bahamas 1
DZ - Algeria 1
EG - Egitto 1
GE - Georgia 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
NA - Namibia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 16.691
Salva come PNG Salva come JPEG
Città #
Moscow 1.830
Dublin 888
Jacksonville 588
Santa Clara 568
Singapore 536
San Jose 531
Hong Kong 475
Chandler 360
Council Bluffs 331
Ashburn 212
Ho Chi Minh City 144
Princeton 123
Medford 105
Hefei 104
Beijing 88
Hanoi 83
Seoul 83
Roxbury 80
Boardman 74
Ann Arbor 73
San Mateo 60
Wilmington 57
Bengaluru 52
New York 51
Cambridge 49
São Paulo 48
Woodbridge 46
The Dalles 44
Naples 42
Dallas 41
Houston 41
Mountain View 37
Los Angeles 35
Milan 31
Zhengzhou 29
Napoli 26
Caserta 24
Des Moines 23
Rome 21
Aversa 19
Da Nang 19
Norwalk 18
Haiphong 17
Nanjing 17
Nuremberg 17
Rio de Janeiro 17
Santa Maria Capua Vetere 17
Salerno 16
Brasília 15
Montreal 15
Vienna 15
Düsseldorf 14
Hải Dương 14
Bremen 13
Brooklyn 13
Brussels 13
Frankfurt am Main 13
Chicago 12
Porto Alegre 11
Tashkent 11
Helsinki 10
London 10
Mexico City 10
Munich 10
Orem 10
Paris 10
Phoenix 10
Shanghai 10
Atlanta 9
Auburn Hills 9
Baghdad 9
Biên Hòa 9
Kunming 9
Memphis 9
Piscataway 9
Tokyo 9
Viterbo 9
Chennai 8
Jinan 8
San Francisco 8
Toronto 8
Belo Horizonte 7
Boston 7
Campinas 7
Curitiba 7
Dearborn 7
Miami 7
Queens 7
Ribeirão Preto 7
Santiago 7
Sorrento 7
Tappahannock 7
Tianjin 7
Venice 7
Buffalo 6
Cava 6
Dhaka 6
Grafing 6
Quito 6
Rimini 6
Totale 8.669
Salva come PNG Salva come JPEG
Nome #
D-Aspartate drinking solution alleviates pain and cognitive impairment in neuropathic mice. 235
Quantitative determination of free D-Asp, LAsp and N-methyl-D-aspartate in mouse brain tissues by chiral separation and Multiple Reaction Monitoring tandem mass spectrometry 205
Age-Related Changes in D-Aspartate Oxidase Promoter Methylation Control Extracellular D-Aspartate Levels and Prevent Precocious Cell Death during Brain Aging 201
Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice 196
D-aspartate modulates nociceptive-specific neuron activity and pain threshold in inflammatory and neuropathic pain condition in mice 196
Caffeine as a psychomotor stimulant: mechanism of action 196
Antibiotic-induced microbiota perturbation causes gut endocannabinoidome changes, hippocampal neuroglial reorganization and depression in mice 191
AMPA receptor expression in mouse testis and spermatogonial GC-1 cells: A study on its regulation by excitatory amino acids 189
Nusinersen mitigates neuroinflammation in severe spinal muscular atrophy patients 178
Olanzapine, but not clozapine, increases glutamate release in the prefrontal cortex of freely moving mice by inhibiting D-aspartate oxidase activity. 175
N-methyl-D-aspartate and dopamine receptor involvement in the modulation of locomotor activity and memory processes 172
Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis 165
N-methyl-D-aspartate receptors in the nucleus accumbens are involved in detection of spatial novelty in mice 161
Machine Learning algorithm unveils glutamatergic alterations in the post-mortem schizophrenia brain 161
Altered dopaminergic innervation and amphetamine response in adult Otx2 conditional mutant mice 156
D-aspartate oxidase gene duplication induces social recognition memory deficit in mice and intellectual disabilities in humans 155
The A1 adenosine receptor as a new player in microglia physiology 154
Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum 154
Bimodal effect of D-aspartate on brain aging processes: insights from animal models. 154
D-aspartate depletion perturbs steroidogenesis and spermatogenesis in mice 148
Adaptations of striatal endocannabinoid system during stress 145
d-Aspartate: An endogenous NMDA receptor agonist enriched in the developing brain with potential involvement in schizophrenia 145
The GTP-binding protein Rhes modulates dopamine signalling in striatal medium spiny neurons 143
A2A Adenosine Receptor Antagonism Enhances Synaptic and Motor Effects of Cocaine via CB1 Cannabinoid Receptor Activation. 143
Analysis of mRNA and Protein Levels of CAP2, DLG1 and ADAM10 Genes in Post‐Mortem Brain of Schizophrenia, Parkinson’s and Alzheimer’s Disease Patients 143
Rasd2 Modulates Prefronto-Striatal Phenotypes in Humans and 'Schizophrenia-Like Behaviors' in Mice. 141
Abnormal RasGRP1 Expression in the Post-Mortem Brain and Blood Serum of Schizophrenia Patients 141
Dysfunctional dopaminergic neurotransmission in asocial BTBR mice. 140
Differential contribution of dopamine D2S and D2L receptors in the modulation of glutamate and GABA transmission in the striatum 140
d-Aspartate activates mGlu receptors coupled to polyphosphoinositide hydrolysis in neonate rat brain slices 140
Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexes 140
Distinct Functions of the two isoforms of dopamine D2 receptors 139
Topographical evaluation of behavioural phenotype in a line of mice with targeted gene deletion of the D2 dopamine receptor 138
Activation of the cAMP/PKA/DARPP-32 signaling pathway is required for morphine psychomotor stimulation but not for morphine reward 137
Changes in extracellular dopamine induced by morphine and cocaine: Crucial control by D2 receptors 136
Absence of dopamine D2 receptors unmasks an inhibitory control over the brain circuitries activated by cocaine 135
Decreased free d -aspartate levels are linked to enhanced d -aspartate oxidase activity in the dorsolateral prefrontal cortex of schizophrenia patients 134
Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein Kinase A site in striatal projection neurons 133
D-aspartate prevents corticostriatal long-term depression and attenuates schizophrenia-like symptoms induced by amphetamine and MK-801. 132
Caffeine drinking potentiates cannabinoid transmission in the striatum: interaction with stress effects 132
Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patients 131
d-Aspartate oxidase influences glutamatergic system homeostasis in mammalian brain 131
Association of GSK-3 beta Genetic Variation With GSK-3 beta Expression, Prefrontal Cortical Thickness, Prefrontal Physiology, and Schizophrenia 131
A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice. 130
Dysregulated balance of D- and L-amino acids modulating glutamatergic neurotransmission in severe spinal muscular atrophy 129
Increased d-aspartate brain content rescues hippocampal age-related synaptic plasticity deterioration of mice 126
Reversal of Metabolic and Neurological Symptoms of Phenylketonuric Mice Treated with a PAH Containing Helper-Dependent Adenoviral Vector 126
Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia 124
Dopaminergic dysfunction is associated with IL-1β-dependent mood alterations in experimental autoimmune encephalomyelitis. 124
Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and post synaptic sites 124
Anti-GluA3 antibodies in frontotemporal dementia: effects on glutamatergic neurotransmission and synaptic failure 124
Cerebrospinal fluid and serum d-serine concentrations are unaltered across the whole clinical spectrum of Alzheimer's disease. 124
New evidence on the role of d‐aspartate metabolism in regulating brain and endocrine system physiology: From preclinical observations to clinical applications 124
Voluntary Exercise and Sucrose Consumption Enhance Cannabinoid CB1 Receptor Sensitivity in the Striatum 123
Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: Role of endogenous acetylcholine 123
D-aspartate dysregulation in Ddo(-/-) mice modulates phencyclidine-induced gene expression changes of postsynaptic density molecules in cortex and striatum. 123
Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPA-induced dyskinesia. 123
Preservation of striatal cannabinoid CB1 receptor function correlates with the anti-anxiety effects of FAAH inhibition 122
Genetic deletion of Rhes or pharmacological blockade of mTORC1 prevent striato-nigral neurons activation in levodopa-induced dyskinesia. 122
The γ-Secretase Modulator CHF5074 Restores Memory and Hippocampal Synaptic Plasticity in Plaque-Free Tg2576 Mice 120
Rhes regulates dopamine D2 receptor transmission in striatal cholinergic interneurons. 120
Modeling DNA methylation by analyzing the individual configurations of single molecules. 120
Motor training compensates for cerebellar dysfunctions caused by oligodendrocytes ablation 119
D-Aspartate: an atypical amino acid with neuromodulatory activity in mammals 119
Loss of striatal cannabinoid CB1 receptor function in attention-deficit/hyperactivity disorder mice with point-mutation of the dopamine transporter 119
Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia 117
Vitamin A deficiency induces motor impairments and striatal cholinergic dysfunction in rats 117
Dysfunctional d-aspartate metabolism in BTBR mouse model of idiopathic autism. 117
Nusinersen Induces Disease-Severity-Specific Neurometabolic Effects in Spinal Muscular Atrophy 116
Role of aberrant striatal dopamine D1 receptor/cAMP/protein kinase A/DARPP32 signaling in the paradoxical calming effect of amphetamine 116
Rhes influences striatal cAMP/PKA-dependent signaling and synaptic plasticity in a gender-sensitive fashion. 116
Free D-aspartate regulates neuronal dendritic morphology, synaptic plasticity, gray matter volume and brain activity in mammals. 115
DNA methylation state of BDNF gene is not altered in prefrontal cortex and striatum of schizophrenia subjects. 115
Dopamine D2 Receptor-Mediated Inhibition of Dopaminergic Neurons in Mice Lacking D2L Receptors 115
DARPP-32 and modulation of cAMP signaling: involvement in motor control and levodopa-induced dyskinesia 114
Histone H3 Phosphorylation is Under the Opposite Tonic Control of Dopamine D2 and Adenosine A2A Receptors in Striatopallidal Neurons 114
Neonatal 192 IgG-saporin lesions of basal forebrain cholinergic neurons selectively impair response to spatial novelty in adult rats 114
Rabphilin 3A: A novel target for the treatment of levodopa-induced dyskinesias 114
The activity of the Spinal Muscular Atrophy protein is regulated during development and cellular differentiation 113
Free D-aspartate triggers NMDA receptor-dependent cell death in primary cortical neurons and perturbs JNK activation, Tau phosphorylation, and protein SUMOylation in the cerebral cortex of mice lacking D-aspartate oxidase activity 113
Decreased free D-aspartate levels in the blood serum of patients with schizophrenia 112
Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors 112
Increased levels of d-aspartate in the hippocampus enhance LTP but do not facilitate cognitive flexibility 112
Otx2 regulates the extent, identity and fate of neuronal progenitor domains in the ventral midbrain 112
Receptor subtypes involved in the presynaptic and postsynaptic actions of dopamine on striatal interneurons 112
Pharmacological validation of a mouse model of Parkinson’s disease and L-DOPA-induced dyskinesia 111
High performance liquid chromatography determination of l-glutamate, l-glutamine and glycine content in brain, cerebrospinal fluid and blood serum of patients affected by Alzheimer’s disease 110
Thyroid hormones and D-aspartic acid, D-aspartate oxidase, D-aspartate racemase, H2O2, and ROS in rats and mice 109
Interleukin-1β Causes Anxiety by Interacting with the Endocannabinoid System. 109
Rhes, a physiologic regulator of sumoylation, enhances cross-sumoylation between the basic sumoylation enzymes E1 and UBC9 108
Modulation of serotonergic transmission by eltoprazine in L-DOPA-induced dyskinesia: Behavioral, molecular, and synaptic mechanisms. 108
Blood D-serine levels correlate with aging and dopaminergic treatment in Parkinson's disease 107
Higher free d-aspartate and N-methyl-d-aspartate levels prevent striatal depotentiation and anticipate l-DOPA-induced dyskinesia 107
Persistent elevation of D-Aspartate enhances NMDA receptor-mediated responses in mouse substantia nigra pars compacta dopamine neurons. 107
The Small GTP-Binding Protein Rhes Influences Nigrostriatal-Dependent Motor Behavior During Aging 107
Regulation of striatal tyrosine hydroxylase phosphorylation by acute and chronic haloperidol 106
Tracking the evolution of epialleles during neural differentiation and brain development: D-Aspartate oxidase as a model gene 106
The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson’s disease patients 105
Effects of caffeine on striatal neurotransmission: focus on cannabinoid CB1 receptors 104
Correction of reference memory and synaptic plasticity impairments of pku mice after a single injection of a helper-dependent adenoviral vector expressing pah 104
Totale 13.314
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.932
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.932
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022662 0 0 0 11 247 6 8 24 24 44 56 242
2022/20231.564 137 8 24 130 132 114 1 81 844 19 33 41
2023/2024547 52 17 15 50 198 37 29 17 2 3 28 99
2024/20252.066 3 5 12 41 319 309 233 167 286 398 173 120
2025/20268.390 219 362 436 421 674 4.800 453 247 372 209 114 83
2026/20271.321 70 306 703 242 0 0 0 0 0 0 0 0
Totale 17.070